Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001860131-25-000004
Filing Date
2025-11-26
Accepted
2025-11-26 18:47:52
Documents
1
Period of Report
2025-11-21

Document Format Files

Seq Description Document Type Size
1 form4-11262025_111148.html 4  
1 form4-11262025_111148.xml 4 11200
  Complete submission text file 0001860131-25-000004.txt   12947
Mailing Address 200 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address 200 CROSSING BOULEVARD FRAMINGHAM MA 01702 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142
Business Address
Audhya Paul K. (Reporting) CIK: 0001860131 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 251531879